Atherosclerosis & Lipoproteins |
From the Divisions of Cardiology (K.D.O., T.O.M., K.E., E.A.K., R.L.) and Metabolism, Endocrinology, and Nutrition (K.L., A.C.), Department of Medicine and Department of Pathobiology (E.A.K., R.C.L.), University of Washington, Seattle; Massachusetts General Hospital (V.K.), Boston, Mass; and Hope Heart Program at the Bennaroya Research Institute (T.N.W.), Seattle, Wash; and Department of Medicine (F.C.d.B.), University of Kentucky, Lexington.
Correspondence to Kevin D. OBrien, MD, Division of Cardiology, Box 356422, University of Washington, Seattle, WA 98195-6422. E-mail cardiac{at}u.washington.edu
Objective Elevated serum amyloid A (SAA) levels are associated with increased cardiovascular risk in humans. Because SAA associates primarily with lipoproteins in plasma and has proteoglycan binding domains, we postulated that SAA might mediate lipoprotein retention on atherosclerotic extracellular matrix.
Methods and Results Immunohistochemistry was performed for SAA, apolipoprotein A-I (apoA-I), apolipoprotein B (apoB), and perlecan on proximal aortic lesions from chow-fed low-density lipoprotein receptor (LDLR)/ and apoE/ mice euthanized at 10, 50, and 70 weeks. SAA was detected on atherosclerotic lesion extracellular matrix at all time points in both strains. SAA area correlated highly with lesion areas (apoE/, r=0.76; LDLR/, r=0.86), apoA-I areas (apoE/, r=0.88; LDLR/, r=0.80), apoB areas (apoE/, r=0.74; LDLR/, r=0.89), and perlecan areas (apoE/, r=0.83; LDLR/, r=0.79) (all P<0.0001). In vitro, SAA enrichment increased high-density lipoprotein (HDL) binding to heparan sulfate proteoglycans, and immunoprecipitation experiments using plasma from apoE/ and LDLR/ mice demonstrated that SAA was present on both apoA-Icontaining and apoB-containing lipoproteins.
Conclusions In chow-fed apoE/ and LDLR/ mice, SAA is deposited in murine atherosclerosis at all stages of lesion development, and SAA immunoreactive area correlates highly with lesion area, apoA-I area, apoB area, and perlecan area. These findings are consistent with a possible role for SAA-mediated lipoprotein retention in atherosclerosis.
In chow-fed apoE/ and LDLR/ mice, serum amyloid A (SAA) is deposited at all stages of atherosclerotic lesion development and SAA immunoreactive area correlates highly with areas for lesions, apoA-I, apoB, and perlecan. These findings are consistent with the hypothesis that SAA may participate in atherosclerotic lesion lipoprotein retention.
Key Words: atherosclerosis lipoproteins perlecan proteoglycans serum amyloid A
This article has been cited by other articles:
![]() |
G. Salguero, H. Schuett, J. Jagielska, R. Schley, E. Tallone, M. Luchtefeld, H. Drexler, W. Muller, K. Grote, and B. Schieffer Hepatocyte gp130 Deficiency Reduces Vascular Remodeling After Carotid Artery Ligation Hypertension, November 1, 2009; 54(5): 1035 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Verschuren, T. Kooistra, J. Bernhagen, P. J. Voshol, D. M. Ouwens, M. van Erk, J. de Vries-van der Weij, L. Leng, J. H. van Bockel, K. W. van Dijk, et al. MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic Disease Circ. Res., July 2, 2009; 105(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jahangiri, M. C. de Beer, V. Noffsinger, L. R. Tannock, C. Ramaiah, N. R. Webb, D. R. van der Westhuyzen, and F. C. de Beer HDL Remodeling During the Acute Phase Response Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moukdar, J. Robidoux, O. Lyght, J. Pi, K. W. Daniel, and S. Collins Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice J. Lipid Res., January 1, 2009; 50(1): 59 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Wilson, J. C. Thompson, N. R. Webb, F. C. de Beer, V. L. King, and L. R. Tannock Serum Amyloid A, but Not C-Reactive Protein, Stimulates Vascular Proteoglycan Synthesis in a Pro-Atherogenic Manner Am. J. Pathol., December 1, 2008; 173(6): 1902 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Lee, S. D. Kim, J. W. Shim, S. Y. Lee, H. Lee, K.-H. Cho, J. Yun, and Y.-S. Bae Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes J. Immunol., September 15, 2008; 181(6): 4332 - 4339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Subramanian, C. Y. Han, T. Chiba, T. S. McMillen, S. A. Wang, A. Haw III, E. A. Kirk, K. D. O'Brien, and A. Chait Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 685 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Stewart, A. Haw III, R. Lopez, T. O. McDonald, J. M. Callaghan, M. J. McConville, K. J. Moore, G. J. Howlett, and K. D. O'Brien Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications J. Lipid Res., October 1, 2007; 48(10): 2162 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bang, S. Bro, E. D. Bartels, T. X. Pedersen, and L. B. Nielsen Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1325 - F1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luchtefeld, H. Schunkert, M. Stoll, T. Selle, R. Lorier, K. Grote, C. Sagebiel, K. Jagavelu, U. J.F. Tietge, U. Assmus, et al. Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man J. Exp. Med., August 6, 2007; 204(8): 1935 - 1944. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Carty, P. Heagerty, K. Nakayama, E. C. McClung, J. Lewis, D. Lum, E. Boespflug, C. McCloud-Gehring, B. R. Soleimani, J. Ranchalis, et al. Inflammatory Response After Influenza Vaccination in Men With and Without Carotid Artery Disease Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2738 - 2744. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kooistra, L. Verschuren, J. de Vries-van der Weij, W. Koenig, K. Toet, H.M.G. Princen, and R. Kleemann Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice: Evidence for Multiple Antiatherogenic Effects Besides Lowering Plasma Cholesterol Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2322 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. M. Boesten, A. S. M. Zadelaar, A. van Nieuwkoop, L. Hu, J. Jonkers, B. van de Water, M. J. J. Gijbels, I. van der Made, M. P. J. de Winther, L. M. Havekes, et al. Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice FASEB J, May 1, 2006; 20(7): 953 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Williams and I. Tabas Lipoprotein Retention--and Clues for Atheroma Regression Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1536 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Tannock, K. D. O'Brien, R. H. Knopp, B. Retzlaff, B. Fish, M. H. Wener, S. E. Kahn, and A. Chait Cholesterol Feeding Increases C-Reactive Protein and Serum Amyloid A Levels in Lean Insulin-Sensitive Subjects Circulation, June 14, 2005; 111(23): 3058 - 3062. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |